UCSF Researchers Identify Major Driver Behind COVID And Long COVID, With Potential Treatment


Authored by Marina Zhang via The Epoch Times Researchers at the University of California San Francisco have identified fibrin, a natural protein involved in blood clotting, as a major driver of the COVID-19 disease, according to a new study. Fibrin binds to proteins from the SARS-CoV-2 virus to form blood clots that are difficult to break down, the […]

A Case Report Highlighting the Significance of COVID-19 Unveiling Megaloblastic Anemia and Worsening Dementia in the Elderly


Pooja Reddy • Pradeep Kumar Devarakonda • Gregory Gotlieb • Pedro Moreno: June 21, 2024,DOI: 10.7759/cureus.62836  Abstract The COVID-19 pandemic has resulted in substantial lifestyle changes with significant implications for nutritional health. Factors such as movement restrictions and disruptions in food supply chains led to the restricted availability of primary sources of essential micronutrients. To highlight this, we present the case of an […]

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches


Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc, et. al. , Frontiers in Medicine The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a significant proportion of them continue to experience health issues weeks, months […]

Systems Modeling Reveals Shared Metabolic Dysregulation and Novel Therapeutic Treatments in ME/CFS and Long COVID


Gong-Hua Li, Feifei Han, Qing-Peng Kong, Wenzhong Xiao, doi: https://doi.org/10.1101/2024.06.17.599450 Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID are complex, multisystemic conditions that pose ongoing challenges to healthcare professionals. Emerging research suggests that ME/CFS and Long COVID exhibit overlapping metabolic symptoms, indicating possible shared metabolic dysfunctions. This study aims to systematically explore these shared metabolic disturbances and their potential treatments. Utilizing our […]

Long Covid Defined


Authors: E. Wesley Ely, M.D., M.P.H. https://orcid.org/0000-0003-3957-2172, Lisa M. Brown, M.P.H., and Harvey V. Fineberg, M.D., Ph.D., for the National Academies of Sciences, Engineering, and Medicine Committee on Examining the Working Definition for Long Covid, DOI: 10.1056/NEJMsb2408466 The Covid-19 pandemic has been perceived mainly as a dangerous acute outbreak of infection that killed more than a million people in the United States and 7 million worldwide.1,2 However, […]

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches


Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2Olga Adriana Caliman Sturdza2,4et. al., Front. Immunol., 03 March 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1344086 The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a […]

Coronavirus Disease Olfactory Dysfunction: A Randomized Controlled Trial


Alex Zxi Jian Ho • Nur Izzati B. Ishak • Eugene Hung Chih Wong, Published: June 06, 2024,DOI: 10.7759/cureus.61855  Abstract Introduction Persistent olfactory dysfunction was seen in many patients upon coronavirus disease 2019 (COVID-19) infection recovery. However, research on its management was very limited, especially among the Southeast Asian population. Objectives We aim to investigate the role of olfactory rehabilitation and […]

Extending Paxlovid Not Effective Against Long COVID


Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for 15 days — three times as long as it’s prescribed for an initial COVID infection — had no better improvement in their long COVID than people taking a placebo, […]

People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.


Findings from the largest UK study of patients hospitalized with SARS-CoV-2 infection show that long COVID leads to ongoing inflammation which can be detected in the blood. In an analysis of more than 650 people who had been hospitalized with severe COVID-19, patients with prolonged symptoms showed evidence of immune system activation. The exact pattern […]

Understanding long COVID: A call for better diagnosis and treatment


By Vijay Kumar Malesu,Mar 7 2024 In a recent review published in the journal Nature Reviews Microbiology, a group of authors summarized recent advancements in understanding long coronavirus disease (COVID) ‘s mechanisms, impacts, and research needs for better diagnostics and treatments. Review: Long COVID: major findings, mechanisms and recommendations Background Long COVID, affecting over 65 million globally, manifests through […]